Navigation Links
AAPM Cautions that Patients Should Not Forgo Essential Medical Imaging
Date:12/19/2011

COLLEGE PARK, Md., Dec. 19, 2011 /PRNewswire-USNewswire/ -- Medical imaging has revolutionized healthcare and is essential in the detection and treatment of injury and disease. Modern equipment and protocols ensure that patients, physicians, and technicians are exposed to the lowest possible amounts of radiation, while still providing accurate results and diagnostic information.

Risks associated with imaging and any medical procedure must be balanced with the benefits of that procedure. Alarmist and sensational speculation about the risk of low-dose radiation exposure may cause patients to refuse these life-saving medical tests.

According to a statement released today by the American Association of Physicists in Medicine (AAPM):

"(AAPM) acknowledges that medical imaging procedures should be appropriate and conducted at the lowest radiation dose consistent with acquisition of the desired information. Discussion of risks related to radiation dose from medical imaging procedures should be accompanied by acknowledgment of the benefits of the procedures. Risks of medical imaging at effective doses below 50 mSv for single procedures or 100 mSv for multiple procedures over short time periods are too low to be detectable and may be nonexistent. Predictions of hypothetical cancer incidence and deaths in patient populations exposed to such low doses are highly speculative and should be discouraged. These predictions are harmful because they lead to sensationalistic articles in the public media that cause some patients and parents to refuse medical imaging procedures, placing them at substantial risk by not receiving the clinical benefits of the prescribed procedures."

The AAPM also stresses that its members in the medical community strive to ensure patient safety while providing the best possible care. As stated:

"AAPM members continually strive to improve medical imaging by lowering radiation levels and maximizing benefits of imaging procedures involving ionizing radiation."

The completed text of the statement is available here: http://www.aapm.org/publicgeneral/StatementMedicalImaging.asp

The AAPM is a scientific and professional organization, founded in 1958, composed of scientists whose clinical practice is dedicated to ensuring accuracy, safety and quality in the use of radiation in medical procedures such as medical imaging and radiation therapy. Medical physicists, as they are generally known, are uniquely positioned across medical specialties due to their responsibility to connect the physician to the patient through the use of radiation producing technology in both diagnosing and treating people. The responsibility of the medical physicist is to assure that the radiation prescribed in imaging and radiation therapy is delivered accurately and safely. One of the primary goals of the AAPM is the identification and implementation of improvements in patient safety for the medical use of radiation in imaging and radiation therapy. To learn more about AAPM, visit www.aapm.org.

Contact:
Charles E. Blue
+1 301-209-3091
cblue@aip.org


'/>"/>
SOURCE American Association of Physicists in Medicine
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DEP Urges Pennsylvanians to Take Precautions to Reduce West Nile Virus Threat
2. DEP Urges Medical Facilities to Take Proper Precautions With X-Ray Equipment to Avoid Health Hazards
3. FDA Cautions on Accurate Vitamin D Supplementation for Infants
4. Waismann Method Medical Director Cautions of Increasing Numbers of Opioid Addicts
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2019)... ... 18, 2019 , ... KVC Kentucky will host the 2nd ... Fasig-Tipton horse farm on May 17, 2019 to raise funds to support KVC ... this elegant venue highlights Kentucky's stunning farmland, prized Thoroughbred horses and beautiful equine ...
(Date:4/17/2019)... ... ... Salt Lake Community College has named Jay K. Francis and ... SLCC’s May 3 Commencement at the Maverik Center, 3200 S. Decker Lake Drive, West ... Family Philanthropy. Richards is president and CEO of SelectHealth. , Francis studied business and ...
(Date:4/17/2019)... HOUSTON (PRWEB) , ... April 17, 2019 , ... What ... improv comedy livestream show? Hosted within the Texas Medical Center’s TMC Innovation Institute, the ... - 26th, 2019, followed by a review by potential employers — all featured in ...
Breaking Medicine Technology:
(Date:4/18/2019)... ... 2019 , ... Swiss Pet company PerAnimal launches a new unique ... between human and animal while improving the overall wellness of pet companions. , All ... of experience. They are made by hand from organic Swiss herbal condensate and Swiss ...
(Date:4/18/2019)... ... ... She went from learning disabled to honor roll – all because of ... “goofy tests,” performed by Deborah Zelinsky, O.D. , founder of the Mind-Eye Institute ... range of visual awareness, she could only see what was directly in front of ...
(Date:4/17/2019)... , ... April 17, 2019 , ... With Fentanyl overdose ... are working to curb the death toll by looking for an alternative to naloxone. ... National Meeting & Exposition this week. , Naloxone (often known by the name brand ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... a new initiative this April to designate April 19th as World IBS Day ... for research & healthcare professionals in their pursuit to find treatments. Irritable Bowel ...
(Date:4/17/2019)... (PRWEB) , ... April 17, 2019 , ... ... focus on advances in revolutionary diagnostic technologies. This episode is scheduled to air ... In this segment, Innovations will focus on Credo Biomedical Pte. Ltd. (Credo Biomedical), ...
Breaking Medicine News(10 mins):